Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
China Greenlights First Stem Cell Therapy On Mixed Clinical Findings
Supportive Regulatory Environment
Jan 07 2025
•
By
Dexter Jie Yan
The hUC-MSC PLEB001 is a human umbilical cord-derived mesenchymal stem cell (MSC) therapy. • Source: Shutterstock
More from Approvals
More from Cell & Gene Therapies